Carol is one of tranScrip’s clinical operations and project management specialists and has been a partner at tranScrip since 2009.
With over 30 years of experience in large pharma companies including Glaxo, Hoechst Marion Roussel and Bayer, as well as a small CRO, Carol has a broad understanding of the industry. She has worked in several therapeutic areas, particularly in infectious diseases, but also respiratory medicine and oncology. Carol has expertise in managing a wide variety of clinical development projects and this has recently included managing clinical operations and overseeing 3 oncology clinical trials for a small biotech; advising on, and supporting the development of a set of SOPs for a new biotech; and project managing a large tranScrip team working on a major regulatory project for a large pharma company.
An understanding of the client’s needs and priorities forms a major driver of Carol’s approach to projects. She has also worked with multi-functional teams within the industry and CRO environments, getting them to pull together towards a mutual goal. Carol possesses skills necessary to oversee objectives, timelines, budget and quality, to proactively risk manage projects.
Carol is a member of the tranScrip Quality Management Committee. She holds an MPhil and a Postgraduate Diploma in Drug Development Sciences from the University of Surrey and an Honours degree in Genetics from Liverpool University. Carol was on the Board of Directors of the Institute of Clinical Research during the period 2011-2013 and was subsequently awarded an HonFICR.